Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

FILE - In this Wednesday, Oct. 16, 2013, file photo Rep. Darrell Issa, R-Calif., arrives for a closed-door meeting on Capitol Hill in Washington. Issa acknowledged Wednesday, Feb. 26, 2014, in his opening statement that federal workers have no right to privacy when using government computers or property. (AP Photo/Susan Walsh)

Republicans blast FDA monitoring of whistleblowers

Matthew Perrone · February 26, 2014 10:25 pm

FDA weighs unknowns of 3-person embryo technique

Matthew Perrone · February 25, 2014 9:51 pm

The FDA announced last month that it was reviewing the safety of drugs like the blockbuster testosterone gel, AndroGel, in light of two recent studies that showed higher rates of cardiovascular problems in men. (AP Photo/The Longmont Times-Call, Richard M. Hackett)

Group wants heart attack warning on testosterone

Matthew Perrone · February 25, 2014 5:00 am

A new fertilization technique that could eventually create babies from the DNA of three people raises a number of ethical questions, including whether the government should sanction the creation of genetically-modified humans. (Thinkstock)

FDA weighs risks of 3-person embryo fertilization

Associated Press, Matthew Perrone · February 24, 2014 3:40 pm

FDA to boost India staff overseeing drug imports

Matthew Perrone · February 21, 2014 9:21 pm

FDA looks to reboot nonprescription drug system

Matthew Perrone · February 21, 2014 5:38 pm

$In this Monday, Feb. 3, 2014, photo, Mary-Jane Harrison spends time with her granddaughter, Robyn, in San Antonio. Like nearly 78 million American adults, Harrison is obese, and because of stress fractures in her legs she is unable to able to walk up or down the stairs of her two-story home. (AP Photo/Eric Gay)$ Business

Few eligible patients can get weight loss surgery

Matthew Perrone · February 14, 2014 3:27 pm

Mary-Jane Harrison plays with her grandson David, in San Antonio. (AP Photo/Eric Gay)

Health plans don’t cover weight loss surgery

Matthew Perrone · February 14, 2014 5:00 am

Panel votes down heart safety claim for naproxen

Matthew Perrone · February 11, 2014 6:30 pm

FILE - In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout Pharmaceuticals said Tuesday, Feb. 11, 2014, that the Food and Drug Administration wants to see more data on how the company's drug, flibanserin, interacts with other medications and how it affects driving ability. Nearly 10 percent of women studied in company trials reported sleepiness while taking the daily pill. (AP Photo/Allen G. Breed)

FDA wants more info on female libido pill

Matthew Perrone · February 11, 2014 5:28 pm

FDA wants more info on female libido pill

Matthew Perrone · February 11, 2014 1:20 pm

(Thinkstock Image)

FDA wants more info on female libido pill

Matthew Perrone · February 11, 2014 5:00 am